A new standard classification and pathophysiology of rosacea, developed by a consensus committee and review panel of 28 rosacea experts worldwide, was recently published.

FDA Alerts

FDA Alerts
Thursday, January 19, 2017
The FDA recently has approved the topical treatment, oxymetazoline hydrochloride (Rhofade, Allergan plc) cream, for patients with persistent facial erythema associated with rosacea in adults.
FDA Alerts
Monday, May 12, 2014
Mirvaso is the first and only FDA-approved topical treatment for persistent erythema of rosacea. The FDA approved Mirvaso (brimonidine) Topical Gel, 0.33% in August 2013 as the first and only topical treatment indicated for the persistent (non-transient) facial erythema of rosacea in adults age 18 or older. The gel, marketed by Galderma Laboratories, L.P., is an alpha-2 adrenergic agonist that may work by constricting the dilated blood vessels to reduce the redness of rosacea. 

News

News
Wednesday, October 25, 2017
The National Rosacea Society has awarded funding for 3 new studies, in addition to continuing support for 3 ongoing studies.
News
Wednesday, August 23, 2017
Recent research, funded by the National Rosacea Society, examined treatment options for patients with rosacea inflammation.
News
Friday, June 2, 2017
Actress and singer Kristin Chenoweth has been named the spokesperson for the campaign “Less Red, More You,” to raise awareness for oxymetazoline hydrochloride (Rhofade; Allergan) cream, 1%.
News
Thursday, April 20, 2017
Women who consume an increased amount of alcohol are at a higher risk of developing rosacea, according to a recent study.

Research in Review

Research in Review
Thursday, November 9, 2017
A new standard classification and pathophysiology of rosacea, developed by a consensus committee and review panel of 28 rosacea experts worldwide, was recently published.
Research in Review
Friday, November 3, 2017
A review of recent news, research, and treatment related to rosacea.
Research in Review
Friday, June 23, 2017
An international panel of experts recommend diagnosing and classifying rosacea based on phenotype rather than by subtype.
Research in Review
Tuesday, April 18, 2017
Rosacea is common but poorly understood condition of the facial skin. New scientific studies are looking at the potential link between rosacea and various comorbidities.